Deutetrabenazine | hsa00120 | Primary bile acid biosynthesis | 3.72E-02 | 2 | P22680, P22307 | CYP7A1, SCP2 | More | |
Deutetrabenazine | hsa00190 | Oxidative phosphorylation | 2.29E-02 | 2 | Q16718, O14521 | NDUFA5, SDHD | More | |
Deutetrabenazine | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
Deutetrabenazine | hsa00591 | Linoleic acid metabolism | 1.34E-03 | 1 | P11712 | CYP2C9 | More | |
Deutetrabenazine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 6.94E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | |
Deutetrabenazine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | |
Deutetrabenazine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.04E-04 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Deutetrabenazine | hsa00982 | Drug metabolism - cytochrome P450 | 1.04E-04 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
Deutetrabenazine | hsa01524 | Platinum drug resistance | 4.67E-02 | 4 | Q13489, P98170, P78417, P43246 | BIRC3, BIRC4, GSTO1, MSH2 | More | |
Deutetrabenazine | hsa02010 | ABC transporters | 2.29E-02 | 2 | P45844, P08183 | ABCG1, ABCB1 | More | |
Deutetrabenazine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | |
Deutetrabenazine | hsa03040 | Spliceosome | 4.87E-03 | 7 | O43143, P08579, P26368, Q13595, Q07955, P84103, Q13243 | DHX15, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS3, SFRS5 | More | |
Deutetrabenazine | hsa03050 | Proteasome | 1.63E-03 | 1 | P55036 | PSMD4 | More | |
Deutetrabenazine | hsa04062 | Chemokine signaling pathway | 3.81E-02 | 6 | P07948, P62873, P63218, P50151, P43250, Q13009 | LYN, GNB1, GNG5, GNG10, GRK6, TIAM1 | More | |
Deutetrabenazine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
Deutetrabenazine | hsa04217 | Necroptosis | 9.70E-04 | 10 | P01375, P01568, P48023, Q13489, P98170, Q14765, P08238, P15104, Q99878, P21796 | TNF, IFNA21, FASLG, BIRC3, BIRC4, STAT4, HSP90AB1, GLUL, H2AC14, VDAC1 | More | |
Deutetrabenazine | hsa04371 | Apelin signaling pathway | 3.23E-04 | 7 | P62873, P63218, P50151, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, SMAD4, SMAD3, CAMK4, CALM1 | More | |
Deutetrabenazine | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | |
Deutetrabenazine | hsa04613 | Neutrophil extracellular trap formation | 2.18E-03 | 7 | P04908, Q93077, P62807, O60814, P68431, O43315, Q16539 | H2AC4; H2AC8, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AQP9, MAPK14 | More | |
Deutetrabenazine | hsa04713 | Circadian entrainment | 1.78E-03 | 5 | O15399, P0DP23, P62873, P63218, P50151 | GRIN2D, CALM1, GNB1, GNG5, GNG10 | More | |
Deutetrabenazine | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | |
Deutetrabenazine | hsa04720 | Long-term potentiation | 2.33E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | |
Deutetrabenazine | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | |
Deutetrabenazine | hsa04724 | Glutamatergic synapse | 1.11E-03 | 5 | O15399, P62873, P63218, P50151, P15104 | GRIN2D, GNB1, GNG5, GNG10, GLUL | More | |
Deutetrabenazine | hsa04725 | Cholinergic synapse | 9.51E-03 | 4 | P62873, P63218, P50151, Q16566 | GNB1, GNG5, GNG10, CAMK4 | More | |
Deutetrabenazine | hsa04726 | Serotonergic synapse | 2.38E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | |
Deutetrabenazine | hsa04727 | GABAergic synapse | 2.45E-03 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | |
Deutetrabenazine | hsa04744 | Phototransduction | 6.94E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | |
Deutetrabenazine | hsa04932 | Non-alcoholic fatty liver disease | 2.44E-03 | 5 | P01375, P49841, P48023, Q16718, O14521 | TNF, GSK3B, FASLG, NDUFA5, SDHD | More | |
Deutetrabenazine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Deutetrabenazine | hsa04976 | Bile secretion | 3.32E-02 | 2 | O43315, P08183 | AQP9, ABCB1 | More | |
Deutetrabenazine | hsa05020 | Prion disease | 3.80E-02 | 4 | Q16718, O14521, P49841, Q16539 | NDUFA5, SDHD, GSK3B, MAPK14 | More | |
Deutetrabenazine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.24E-02 | 6 | P49841, Q16718, O14521, Q13561, Q16539, Q08752 | GSK3B, NDUFA5, SDHD, DCTN2, MAPK14, PPID | More | |
Deutetrabenazine | hsa05032 | Morphine addiction | 1.34E-02 | 4 | P62873, P63218, P50151, P43250 | GNB1, GNG5, GNG10, GRK6 | More | |
Deutetrabenazine | hsa05034 | Alcoholism | 4.45E-05 | 11 | O15399, Q16566, P0DP23, P62873, P63218, P50151, Q93077, P62807, Q93079, O60814, P68431 | GRIN2D, CAMK4, CALM1, GNB1, GNG5, GNG10, HIST1H2AC, HIST1H2BC, H2BC9, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Deutetrabenazine | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | |
Deutetrabenazine | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | |
Deutetrabenazine | hsa05163 | Human cytomegalovirus infection | 2.00E-02 | 6 | P62873, P63218, P50151, P0DP23, P30101, P01568 | GNB1, GNG5, GNG10, CALM1, PDIA3, IFNA21 | More | |
Deutetrabenazine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 2.00E-02 | 6 | P01568, P62873, P63218, P50151, P07948, P0DP23 | IFNA21, GNB1, GNG5, GNG10, LYN, CALM1 | More | |
Deutetrabenazine | hsa05168 | Herpes simplex virus 1 infection | 4.43E-02 | 8 | P01568, Q07955, P84103, Q13243, Q13489, P30101, Q13398, Q9NZL3 | IFNA21, SFRS1, SFRS3, SFRS5, BIRC3, PDIA3, ZNF211, ZNF224 | More | |
Deutetrabenazine | hsa05170 | Human immunodeficiency virus 1 infection | 1.83E-02 | 7 | P62873, P63218, P50151, P0DP23, P30101, P01568, P23528 | GNB1, GNG5, GNG10, CALM1, PDIA3, IFNA21, CFL1 | More | |
Deutetrabenazine | hsa05200 | Pathways in cancer | 3.99E-04 | 15 | Q13751, P08238, P43246, P84022, Q13485, Q13489, P98170, P62873, P63218, P50151, P78417, O75293, P0DP23, P01568, P01042 | LAMB3, HSP90AB1, MSH2, SMAD3, SMAD4, BIRC3, BIRC4, GNB1, GNG5, GNG10, GSTO1, GADD45B, CALM1, IFNA21, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.868 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.724 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.742 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.847 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.899 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.715 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P98170 | BIRC4 | E3 ubiquitin-protein ligase XIAP | 0.716 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | 0.754 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.708 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P0DP23 | CALM1 | Calmodulin-1 | -0.724 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01568 | IFNA21 | Interferon alpha-21 | 0.703 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01042 | KNG1 | Kininogen-1 | 0.708 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.868 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.724 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.742 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.847 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.899 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.715 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P98170 | BIRC4 | E3 ubiquitin-protein ligase XIAP | 0.716 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | 0.754 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.708 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P0DP23 | CALM1 | Calmodulin-1 | -0.724 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01568 | IFNA21 | Interferon alpha-21 | 0.703 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01042 | KNG1 | Kininogen-1 | 0.708 |
|
Deutetrabenazine | hsa05203 | Viral carcinogenesis | 3.28E-03 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | |
Deutetrabenazine | hsa05204 | Chemical carcinogenesis | 2.96E-04 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Deutetrabenazine | hsa05210 | Colorectal cancer | 4.67E-02 | 4 | P84022, Q13485, P43246, O75293 | SMAD3, SMAD4, MSH2, GADD45B | More | |
Deutetrabenazine | hsa05212 | Pancreatic cancer | 3.28E-02 | 3 | P84022, Q13485, O75293 | SMAD3, SMAD4, GADD45B | More | |
Deutetrabenazine | hsa05214 | Glioma | 3.28E-02 | 3 | P0DP23, Q16566, O75293 | CALM1, CAMK4, GADD45B | More | |
Deutetrabenazine | hsa05222 | Small cell lung cancer | 3.80E-02 | 4 | Q13751, Q13489, P98170, O75293 | LAMB3, BIRC3, BIRC4, GADD45B | More | |
Deutetrabenazine | hsa05225 | Hepatocellular carcinoma | 4.54E-02 | 3 | Q92922, P78417, Q9NPI1 | SMARCC1, GSTO1, BRD7 | More | |
Deutetrabenazine | hsa05322 | Systemic lupus erythematosus | 1.73E-05 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Deutetrabenazine | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Deutetrabenazine | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Deutetrabenazine | hsa05415 | Diabetic cardiomyopathy | 1.28E-02 | 4 | Q16718, O14521, Q16539, P49841 | NDUFA5, SDHD, MAPK14, GSK3B | More | |
Tetrabenazine | hsa00120 | Primary bile acid biosynthesis | 3.72E-02 | 2 | P22680, P22307 | CYP7A1, SCP2 | More | |
Tetrabenazine | hsa00190 | Oxidative phosphorylation | 2.29E-02 | 2 | Q16718, O14521 | NDUFA5, SDHD | More | |
Tetrabenazine | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | |
Tetrabenazine | hsa00591 | Linoleic acid metabolism | 1.34E-03 | 1 | P11712 | CYP2C9 | More | |
Tetrabenazine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 6.94E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | |
Tetrabenazine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | |
Tetrabenazine | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.04E-04 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Tetrabenazine | hsa00982 | Drug metabolism - cytochrome P450 | 1.04E-04 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | |
Tetrabenazine | hsa01524 | Platinum drug resistance | 4.67E-02 | 4 | Q13489, P98170, P78417, P43246 | BIRC3, BIRC4, GSTO1, MSH2 | More | |
Tetrabenazine | hsa02010 | ABC transporters | 2.29E-02 | 2 | P45844, P08183 | ABCG1, ABCB1 | More | |
Tetrabenazine | hsa03022 | Basal transcription factors | 3.32E-02 | 2 | O00268, Q15544 | TAF4, TAF11 | More | |
Tetrabenazine | hsa03040 | Spliceosome | 4.87E-03 | 7 | O43143, P08579, P26368, Q13595, Q07955, P84103, Q13243 | DHX15, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS3, SFRS5 | More | |
Tetrabenazine | hsa03050 | Proteasome | 1.63E-03 | 1 | P55036 | PSMD4 | More | |
Tetrabenazine | hsa04062 | Chemokine signaling pathway | 3.81E-02 | 6 | P07948, P62873, P63218, P50151, P43250, Q13009 | LYN, GNB1, GNG5, GNG10, GRK6, TIAM1 | More | |
Tetrabenazine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | |
Tetrabenazine | hsa04217 | Necroptosis | 9.70E-04 | 10 | P01375, P01568, P48023, Q13489, P98170, Q14765, P08238, P15104, Q99878, P21796 | TNF, IFNA21, FASLG, BIRC3, BIRC4, STAT4, HSP90AB1, GLUL, H2AC14, VDAC1 | More | |
Tetrabenazine | hsa04371 | Apelin signaling pathway | 3.23E-04 | 7 | P62873, P63218, P50151, Q13485, P84022, Q16566, P0DP23 | GNB1, GNG5, GNG10, SMAD4, SMAD3, CAMK4, CALM1 | More | |
Tetrabenazine | hsa04530 | Tight junction | 3.29E-02 | 3 | P16989, P56750, Q14247 | CSDA, CLDN17, CTTN | More | |
Tetrabenazine | hsa04613 | Neutrophil extracellular trap formation | 2.18E-03 | 7 | P04908, Q93077, P62807, O60814, P68431, O43315, Q16539 | H2AC4; H2AC8, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, AQP9, MAPK14 | More | |
Tetrabenazine | hsa04713 | Circadian entrainment | 1.78E-03 | 5 | O15399, P0DP23, P62873, P63218, P50151 | GRIN2D, CALM1, GNB1, GNG5, GNG10 | More | |
Tetrabenazine | hsa04714 | Thermogenesis | 5.21E-03 | 4 | Q16539, P33121, Q16718, O14521 | MAPK14, ACSL1, NDUFA5, SDHD | More | |
Tetrabenazine | hsa04720 | Long-term potentiation | 2.33E-02 | 3 | Q16566, P0DP23, O15399 | CAMK4, CALM1, GRIN2D | More | |
Tetrabenazine | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | |
Tetrabenazine | hsa04724 | Glutamatergic synapse | 1.11E-03 | 5 | O15399, P62873, P63218, P50151, P15104 | GRIN2D, GNB1, GNG5, GNG10, GLUL | More | |
Tetrabenazine | hsa04725 | Cholinergic synapse | 9.51E-03 | 4 | P62873, P63218, P50151, Q16566 | GNB1, GNG5, GNG10, CAMK4 | More | |
Tetrabenazine | hsa04726 | Serotonergic synapse | 2.38E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | |
Tetrabenazine | hsa04727 | GABAergic synapse | 2.45E-03 | 4 | P62873, P63218, P50151, P15104 | GNB1, GNG5, GNG10, GLUL | More | |
Tetrabenazine | hsa04740 | Olfactory transduction | 2.52E-02 | 1 | Q9H255 | OR51E2 | More | |
Tetrabenazine | hsa04742 | Taste transduction | 1.01E-02 | 1 | P30939 | HTR1F | More | |
Tetrabenazine | hsa04744 | Phototransduction | 6.94E-03 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | |
Tetrabenazine | hsa04932 | Non-alcoholic fatty liver disease | 2.44E-03 | 5 | P01375, P49841, P48023, Q16718, O14521 | TNF, GSK3B, FASLG, NDUFA5, SDHD | More | |
Tetrabenazine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Tetrabenazine | hsa04976 | Bile secretion | 3.32E-02 | 2 | O43315, P08183 | AQP9, ABCB1 | More | |
Tetrabenazine | hsa05020 | Prion disease | 3.80E-02 | 4 | Q16718, O14521, P49841, Q16539 | NDUFA5, SDHD, GSK3B, MAPK14 | More | |
Tetrabenazine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.24E-02 | 6 | P49841, Q16718, O14521, Q13561, Q16539, Q08752 | GSK3B, NDUFA5, SDHD, DCTN2, MAPK14, PPID | More | |
Tetrabenazine | hsa05032 | Morphine addiction | 1.34E-02 | 4 | P62873, P63218, P50151, P43250 | GNB1, GNG5, GNG10, GRK6 | More | |
Tetrabenazine | hsa05034 | Alcoholism | 4.45E-05 | 11 | O15399, Q16566, P0DP23, P62873, P63218, P50151, Q93077, P62807, Q93079, O60814, P68431 | GRIN2D, CAMK4, CALM1, GNB1, GNG5, GNG10, HIST1H2AC, HIST1H2BC, H2BC9, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Tetrabenazine | hsa05143 | African trypanosomiasis | 2.72E-02 | 2 | P01375, P48023 | TNF, FASLG | More | |
Tetrabenazine | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | |
Tetrabenazine | hsa05163 | Human cytomegalovirus infection | 2.00E-02 | 6 | P62873, P63218, P50151, P0DP23, P30101, P01568 | GNB1, GNG5, GNG10, CALM1, PDIA3, IFNA21 | More | |
Tetrabenazine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 2.00E-02 | 6 | P01568, P62873, P63218, P50151, P07948, P0DP23 | IFNA21, GNB1, GNG5, GNG10, LYN, CALM1 | More | |
Tetrabenazine | hsa05168 | Herpes simplex virus 1 infection | 4.43E-02 | 8 | P01568, Q07955, P84103, Q13243, Q13489, P30101, Q13398, Q9NZL3 | IFNA21, SFRS1, SFRS3, SFRS5, BIRC3, PDIA3, ZNF211, ZNF224 | More | |
Tetrabenazine | hsa05170 | Human immunodeficiency virus 1 infection | 1.83E-02 | 7 | P62873, P63218, P50151, P0DP23, P30101, P01568, P23528 | GNB1, GNG5, GNG10, CALM1, PDIA3, IFNA21, CFL1 | More | |
Tetrabenazine | hsa05200 | Pathways in cancer | 3.99E-04 | 15 | Q13751, P08238, P43246, P84022, Q13485, Q13489, P98170, P62873, P63218, P50151, P78417, O75293, P0DP23, P01568, P01042 | LAMB3, HSP90AB1, MSH2, SMAD3, SMAD4, BIRC3, BIRC4, GNB1, GNG5, GNG10, GSTO1, GADD45B, CALM1, IFNA21, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.868 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.724 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.742 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.847 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.899 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.715 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P98170 | BIRC4 | E3 ubiquitin-protein ligase XIAP | 0.716 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | 0.754 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.708 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P0DP23 | CALM1 | Calmodulin-1 | -0.724 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01568 | IFNA21 | Interferon alpha-21 | 0.703 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01042 | KNG1 | Kininogen-1 | 0.708 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.868 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.724 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.742 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.847 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.899 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.715 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P98170 | BIRC4 | E3 ubiquitin-protein ligase XIAP | 0.716 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.709 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.759 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.744 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | 0.754 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.708 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P0DP23 | CALM1 | Calmodulin-1 | -0.724 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01568 | IFNA21 | Interferon alpha-21 | 0.703 | Q96KQ7 | EHMT2 | Histone-lysine N-methyltransferase EHMT2 | P01042 | KNG1 | Kininogen-1 | 0.708 |
|
Tetrabenazine | hsa05203 | Viral carcinogenesis | 3.28E-03 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | |
Tetrabenazine | hsa05204 | Chemical carcinogenesis | 2.96E-04 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | |
Tetrabenazine | hsa05210 | Colorectal cancer | 4.67E-02 | 4 | P84022, Q13485, P43246, O75293 | SMAD3, SMAD4, MSH2, GADD45B | More | |
Tetrabenazine | hsa05212 | Pancreatic cancer | 3.28E-02 | 3 | P84022, Q13485, O75293 | SMAD3, SMAD4, GADD45B | More | |
Tetrabenazine | hsa05214 | Glioma | 3.28E-02 | 3 | P0DP23, Q16566, O75293 | CALM1, CAMK4, GADD45B | More | |
Tetrabenazine | hsa05222 | Small cell lung cancer | 3.80E-02 | 4 | Q13751, Q13489, P98170, O75293 | LAMB3, BIRC3, BIRC4, GADD45B | More | |
Tetrabenazine | hsa05225 | Hepatocellular carcinoma | 4.54E-02 | 3 | Q92922, P78417, Q9NPI1 | SMARCC1, GSTO1, BRD7 | More | |
Tetrabenazine | hsa05322 | Systemic lupus erythematosus | 1.73E-05 | 5 | P09871, Q93077, P62807, O60814, P68431 | C1S, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | |
Tetrabenazine | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Tetrabenazine | hsa05332 | Graft-versus-host disease | 3.70E-02 | 2 | P48023, P01375 | FASLG, TNF | More | |
Tetrabenazine | hsa05415 | Diabetic cardiomyopathy | 1.28E-02 | 4 | Q16718, O14521, Q16539, P49841 | NDUFA5, SDHD, MAPK14, GSK3B | More | |